Vaccines Related News
Clinical trial finds temperature-stable TB vaccine safe and effective
A clinical trial testing a freeze-dried, temperature-stable experimental tuberculosis (TB) vaccine in healthy adults found it was safe.
A phase 1 trial, supported by the...
Defence advances to phase I clinical trials of the Accum technology
Defence Therapeutics Inc. is pleased to update its stakeholders on its completed achievements and outline the future milestones for AccumTM set for 2023.
Over the...
NICE recommends three treatments for COVID-19
The National Institute for Health and Care Excellence (NICE) has recommended three treatments for COVID-19 that are cost-effective.
Everyone with COVID-19 at the highest risk...
Evusheld not recommended for vulnerable adults with COVID-19
NICE has not recommended Evusheld for vulnerable adults in England with COVID-19 due to a lack of evidence of its effectiveness.
Evusheld is used to...
Can the BCG vaccine combat cancer and autoimmune diseases?
Researchers have proposed that the 100-year-old BCG vaccine, originally used for tuberculosis, could be effective against cancer and autoimmune diseases.
At the beginning of the...
Defence Therapeutics begins manufacturing of it’s ARM vaccine
Defence Therapeutics Inc., a Canadian biopharmaceutical company specialising in the development of immune-oncology vaccines and drug delivery technologies, is pleased to announce the start...
The TB vaccine does not protect elderly patients from COVID-19
The TB vaccine does not protect the elderly against disease symptoms caused by COVID-19, according to researchers in the Netherlands.
These findings come from a...
74% of UK parents support routine chickenpox vaccine
Almost three-quarters of UK parents would support the chickenpox vaccine being added to the childhood vaccination schedule.
The chickenpox vaccine protects against the varicella-zoster virus...
Defence Therapeutics has melanoma vaccine validated
Defence Therapeutics Inc., a Canadian biopharmaceutical company specialising in the development of immune-oncology vaccines and drug delivery technologies, is pleased to report the validation...
New discovery could lead Epstein-Barr virus vaccines
Researchers from MedUni Vienna have found a specific immune response to the virus Epstein-Barr virus that could help the development of new vaccines.
The research...
Defence Therapeutics launch Accum-mRNA vaccine programme
Defence Therapeutics Inc., a Canadian biopharmaceutical company specialising in the development of immune-oncology vaccines and drug delivery technologies, is pleased to announce the advancement...
COVID-19 infection and vaccination provide protection against omicron BA.5
A study from the University of Lisbon has shown that vaccination and previous COVID-19 infection grants protection against omicron BA.5.
The study was led by...
WHO update guidelines on HPV vaccination
The World Health Organization (WHO) has recently published a paper outlining updates to their recommendations for the human papillomavirus (HPV) vaccine.
Notably, the paper states...
Over 40,000 doses of Oxford’s Ebola vaccine heading to Uganda
University of Oxford’s Ebola vaccine has been manufactured by SII (Serum Institute of India) in just 60 days and doses shipped to Uganda.
Oxford’s Ebola vaccine...
New mRNA cancer vaccine significantly reduces disease
An mRNA cancer vaccine, developed by Moderna and Merck, demonstrated a statistically significant and clinically meaningful reduction in risk of disease recurrence or death.
The...
Is it time TB vaccines were improved?
A new study commissioned by the World Health Organization (WHO) has predicted high health and economic returns from investment in new TB vaccines.
According to...
The uptake of MMR vaccines is lower in deprived neighbourhoods
Only 75% of children are receiving their first dose of MMR vaccines on time, according to a Queen Mary University study.
A 95% uptake of...
NHS offers second monkeypox vaccination for eligible people
The NHS will now offer a second monkeypox vaccination to everyone who is eligible in an effort to provide long-term protection against the virus.
Around...
40 million children are dangerously susceptible to the measles virus
New data from WHO and the CDC confirms that almost 40 million children worldwide are becoming dangerously susceptible to the measles virus.
The measles virus...
Defence’s successful study on the ACCUVAC-PT007 vaccine
Defence Therapeutics Inc. has announced its successful study on its ACCUVAC-PT007 vaccine, which targets cervical cancer.
Defence Therapeutics Inc. a Canadian biopharmaceutical company specialised in...
